updated standardized definitions for efficacy end points in adjuvant breast cancer clinical trials
Published 3 years ago • 215 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
58:29
clinical trials 101 | 2022-2023 embrace mbc virtual forum series
-
1:22
atempt breast cancer study | dana-farber cancer institute
-
39:15
metastatic breast cancer forum 2018: clinical trials 101 | dana-farber cancer institute
-
20:23
phase i clinical trials overview | dana-farber cancer institute
-
18:00
ibc research updates | dana-farber ibc program 2022 patient forum
-
1:56
how clinicals trial differ from standard care in metastatic breast cancer treatment
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
23:00
what's new in metastatic breast cancer research | dana-farber cancer institute
-
22:26
triple-negative breast cancer: what's new in treatment and research at mbc patient forum 2019
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
2:12
using clinical trials in treatment: dr. sara tolaney | dana-farber cancer institute
-
3:45
new treatments for metastatic breast cancer
-
26:11
live webchat: choosing a clinical trial for metastatic breast cancer
-
59:15
2021 san antonio breast cancer symposium update on mbc | 2021-2022 embrace mbc virtual forum series
-
21:39
new research in metastatic breast cancer | sabcs 2019
-
32:15
clinical trials for brain tumor patients | dana-farber cancer institute